Advances in Transdermal Drug Delivery Systems Driving Innovation in Modern Therapeutics
Transdermal drug delivery has evolved into a critical segment of modern pharmaceutical innovation, offering controlled, non-invasive, and patient-friendly alternatives to conventional drug administration routes. By enabling drugs to be absorbed through the skin into systemic circulation, these systems bypass gastrointestinal degradation and first-pass metabolism, thereby improving bioavailability and therapeutic efficiency. Advances in material science, nanotechnology, and digital health integration are accelerating the adoption of transdermal solutions across multiple therapeutic areas. The global transdermal drug delivery systems market size was estimated at USD 62,481.8 million in 2023 and is projected to reach USD 136,744.2 million by 2030, growing at a CAGR of 11.8% from 2024 to 2030. The market for transdermal drug delivery systems is experiencing a surge in demand due to the increasing incidence of chronic diseases. This growth is supported by the rising preval...